Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2

被引：52

|

作者：

Bressler, NM

机构：

来源：

AMERICAN JOURNAL OF OPHTHALMOLOGY | 2002年 / 133卷 / 01期

关键词：

D O I：

10.1016/S0002-9394(01)01237-5

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

收藏

页码：168 / 169

页数：2

相关论文

共 50 条

[31] Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy
Ghazi, NG
Jabbour, NM
De la Cruz, ZC
Green, WR
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2001, 21 (05): : 478 - 486
[32] Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration
Pece, Alfredo
Isola, Vincenzo
Vadala, Maria
Calori, Giliola
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (03): : 342 - 348
[33] Verteporfin ocular photodynamic therapy combined with macular scatter photocoagulation for occult or predominantly occult subfoveal neovascularization in age-related macular degeneration
Peyman, GA
Canakis, C
Livir-Rallatos, C
Naaman, GJ
Conway, MD
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U114 - U114
[34] Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extensionTAP Report No. 8
Peter K. Kaiser
Graefe's Archive for Clinical and Experimental Ophthalmology, 2006, 244 : 1132 - 1142
[35] Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration
Gilson, Marta M.
Bressler, Neil M.
Jabs, Douglas A.
Solomon, Sharon D.
Thorne, Jennifer E.
Wilson, David J.
OPHTHALMOLOGY, 2007, 114 (09) : 1713 - 1721
[36] Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials - TAP report 1 (vol 117, pg 1329, 1999)
Bressler, NM
ARCHIVES OF OPHTHALMOLOGY, 2000, 118 (04) : 488 - 488
[37] Cost-effectiveness of photodynamic therapy with verteporfin for choroidal neovascularization in age-related macular degeneration in routine clinical practice in Switzerland
Donati, G.
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2007, 30 (08): : 837 - 841
[38] Verteporfin therapy with delayed light application for the treatment of occult choroidal neovascularization (CNV) in age-related macular degeneration (AMD)
Rosenfeld, PJ
Suner, I
Cruz-Villegas, V
Villate, N
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U215 - U215
[39] Photodynamic therapy of subfoveal choroidal neovascularization (CNV) in pathologic myopia using verteporfin: Two-year results - VIP report #4.
Lim, JI
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S304 - S304
[40] Radiotherapy for subfoveal choroidal neovascularization in age-related macular degeneration: A randomized clinical trial
Valmaggia, C
Ries, G
Ballinari, P
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2002, 133 (04) : 521 - 529

← 1 2 3 4 5 →